Monoclonal gammopathy of undetermined significance history and symptoms: Difference between revisions
Shyam Patel (talk | contribs) No edit summary |
|||
| (5 intermediate revisions by one other user not shown) | |||
| Line 2: | Line 2: | ||
{{Monoclonal gammopathy of undetermined significance }} | {{Monoclonal gammopathy of undetermined significance }} | ||
{{CMG}}; {{AE}} {{OK}} | {{CMG}} {{shyam}}; {{AE}} {{OK}} | ||
==Overview== | ==Overview== | ||
The majority of patients with | The majority of patients with [[monoclonal gammopathy of undetermined significance]] are asymptomatic. Patients with MGUS have no symptoms of myeloma or related malignancy that can be attributable to their monoclonal protein. MGUS commonly arises during evaluation for one of a variety of clinical symptoms and disorders that include peripheral neuropathy, [[vasculitis]], [[hemolytic anemia]], [[skin rashes]], [[hypercalcemia]], and elevated [[erythrocyte sedimentation rate]]. It is often an incidental finding on [[protein electrophoresis]]. | ||
==History and Symptoms== | ==History and Symptoms== | ||
[[Monoclonal gammopathy of undetermined significance]] patients are mostly asymptomatic. Discovered often incidentally during diagnosis of other organic [[diseases]], there are usually no history or symptoms at all.<ref name="pmid22883742">{{cite journal |vauthors=Therneau TM, Kyle RA, Melton LJ, Larson DR, Benson JT, Colby CL, Dispenzieri A, Kumar S, Katzmann JA, Cerhan JR, Rajkumar SV |title=Incidence of monoclonal gammopathy of undetermined significance and estimation of duration before first clinical recognition |journal=Mayo Clin. Proc. |volume=87 |issue=11 |pages=1071–9 |date=November 2012 |pmid=22883742 |pmc=3541934 |doi=10.1016/j.mayocp.2012.06.014 |url=}}</ref> | |||
=== | |||
=== | |||
==References== | ==References== | ||
Latest revision as of 03:18, 3 January 2019
|
Monoclonal gammopathy of undetermined significance Microchapters |
|
Differentiating Monoclonal gammopathy of undetermined significance from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Monoclonal gammopathy of undetermined significance history and symptoms On the Web |
|
American Roentgen Ray Society Images of Monoclonal gammopathy of undetermined significance history and symptoms |
|
FDA on Monoclonal gammopathy of undetermined significance history and symptoms |
|
on Monoclonal gammopathy of undetermined significance history and symptoms |
|
Monoclonal gammopathy of undetermined significance history and symptoms in the news |
|
Blogs on Monoclonal gammopathy of undetermined significance history and symptoms |
|
Directions to Hospitals Treating Monoclonal gammopathy of undetermined significance |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Shyam Patel [2]; Associate Editor(s)-in-Chief: Omer Kamal, M.D.[3]
Overview
The majority of patients with monoclonal gammopathy of undetermined significance are asymptomatic. Patients with MGUS have no symptoms of myeloma or related malignancy that can be attributable to their monoclonal protein. MGUS commonly arises during evaluation for one of a variety of clinical symptoms and disorders that include peripheral neuropathy, vasculitis, hemolytic anemia, skin rashes, hypercalcemia, and elevated erythrocyte sedimentation rate. It is often an incidental finding on protein electrophoresis.
History and Symptoms
Monoclonal gammopathy of undetermined significance patients are mostly asymptomatic. Discovered often incidentally during diagnosis of other organic diseases, there are usually no history or symptoms at all.[1]
References
- ↑ Therneau TM, Kyle RA, Melton LJ, Larson DR, Benson JT, Colby CL, Dispenzieri A, Kumar S, Katzmann JA, Cerhan JR, Rajkumar SV (November 2012). "Incidence of monoclonal gammopathy of undetermined significance and estimation of duration before first clinical recognition". Mayo Clin. Proc. 87 (11): 1071–9. doi:10.1016/j.mayocp.2012.06.014. PMC 3541934. PMID 22883742.